The mechanism of cholera toxin adjuvanticity.
Lycke
N
N
Department of Medical Microbiology & Immunology, University of Göteborg, Sweden.
D000276:Adjuvants, Immunologic; D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology; D017951:Antigen Presentation / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D016827:CD8 Antigens / Q000235:genetics / Q000276:immunology; D002454:Cell Differentiation; D002772:Cholera Toxin / Q000737:chemistry / Q000276:immunology*; D018390:Gene Targeting; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D009061:Mouth Mucosa / Q000276:immunology; D011065:Poly(ADP-ribose) Polymerases / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
D000276:Adjuvants, Immunologic; D000907:Antibodies, Bacterial; D016827:CD8 Antigens; D002772:Cholera Toxin; D011065:Poly(ADP-ribose) Polymerases